Neurocrine Biosciences | سهم



Stock تغيير تاريخ
AbbVie USD 4.53B 345M 2025-03
Acadia Pharmaceuticals USD 26.12M 3.18M 2025-06
Agios Pharmaceuticals USD 30.85M 1.24M 2025-06
ALKERMES USD 191.92M 8.49M 2025-06
Alnylam Pharmaceuticals USD 71.69M 6.11M 2025-06
Amgen USD 6.58B 146M 2025-06
Biogen USD 2.27B 400K 2025-06
BioMarin Pharmaceutical USD 1.34B 65.32M 2025-06
Cytokinetics 0 0 2023-12
Dynavax Technologies USD 75.69M 1.28M 2025-06
Exelixis USD 23.48M 1.37M 2025-06
Gilead Sciences USD 1.83B 66M 2025-06
Halozyme Therapeutics USD 181.5M 16.64M 2025-06
Incyte USD 83.42M 19.45M 2025-06
Ionis Pharmaceuticals USD 8.48M 3.02M 2025-06
Neurocrine Biosciences USD 56.9M 2.2M 2025-06
Pfizer USD 11.67B 817M 2025-06
Regeneron Pharmaceuticals USD 3.21B 760.7M 2025-06
Repligen USD 153.11M 10.15M 2025-03
Sarepta Therapeutics USD 994.04M 52.6M 2025-06
Teva Pharmaceutical Industries USD 3.5B 250M 2025-06
Ultragenyx Pharmaceutical USD 46.5M 467K 2025-06
Vertex Pharmaceuticals USD 1.5B 139.6M 2025-06


Neurocrine Biosciences سهم - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.